Daiichi Sankyo public
[search 0]
More

Download the App!

show episodes
 
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
 
Loading …
show series
 
A $900 raise, gene therapy news, a quick IPO, and merge three for $100M Find out more at https://LifeScienceTodayPodcast.com Story References Alnylam, Link 2, Link 3 Intellia Therapeutics Third Harmonic Bio Galvanize Therapeutics About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Exp…
 
A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. Find out more at https://LifeScienceTodayPodcast.com Story References Revance Velocity + MedPharmics Arsenal SpringWorks Link 1, Link 2, Link 3 About the Show Life Science Today is your source for stories, insights, and trends acros…
 
A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines. Find out more at https://LifeScienceTodayPodcast.com Story References Novo + Forma Sanofi Boehringer Ingelheim Arcturus About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technolo…
 
Ophthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related. Find out more at https://LifeScienceTodayPodcast.com Story References Alcon + Aerie Novartis + Sandoz Labcorp + RWJBH About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. E…
 
Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership. Find out more at https://LifeScienceTodayPodcast.com Story References Bluebird Endo & Pharmacies Genentech + Jemincare Merck + Orna About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekl…
 
Spending that COVID money, brain money, Irish money, and another oncology approval. Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer Cerevel Abbott AstraZeneca + Daiichi Sankyo About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights abo…
 
This week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives? Find out more at https://LifeScienceTodayPodcast.com Story References Zymergen + Ginkgo Cassava Teva About the Show Life Science Today is your s…
 
There’s a SPAC, expanded FDA approval, more of the common, and two Bs, two As Find out more at https://LifeScienceTodayPodcast.com Story References ZyVersa Incyte Revolution Frontera CAMP4 ForSight Auron About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights abou…
 
Cell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital Find out more at https://LifeScienceTodayPodcast.com Story References Vertex + ViaCyte Theravance Biopharma Merck + Orion Pliant Therapeutics Qiming About the Show Life Science Today is your source for stories, insights, and trends across the…
 
FEED DROP - Clinical Research Evolved Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth. Find Out More Dan A…
 
Double acquisition, private money, affordable deals, and a surprising $70M launch Find out more at https://LifeScienceTodayPodcast.com Story References Galapagos + CellPoint + AboundBio Radius Ipsen + Epizyme DEM Bio About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly hi…
 
Crohn’s approval, new VC round, direct offerings, and potential asset sales. Find out more at https://LifeScienceTodayPodcast.com Story References AbbVie Third Rock Scholar Rock Kyowa Kirin About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technolo…
 
Gene therapy, minor legislation, a $625M series D, and four companies raise $373M. Find out more at https://LifeScienceTodayPodcast.com Story References BlueBird FDA Resilience Corvia, Code, Mineralys, Tessa About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights …
 
Pharma buys, pharma splits, pharma trades, and oncology biobucks from pharma Find out more at https://LifeScienceTodayPodcast.com Story References GSK + Affinivax Pfizer – Haleon Regeneron Roche + Repare About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights abou…
 
Pox progress, an oncology acquisition, and we look at $360M worth of biotech funding Find out more at https://LifeScienceTodayPodcast.com Story References Chimerix, Emergent, SIGA Merck & Kelun Inceptor, Laekna, Kriya About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly h…
 
An $11.6B yes, $11.7B delay, drop the A1C with GLP, and a billion bio-bucks Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer + Biohaven Regulators Lilly BridgeBio + BMS About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new t…
 
Resets for biotech, antibiotics approval not enough, continued consolidation, and a normal deal Find out more at https://LifeScienceTodayPodcast.com Story References Zymeworks Phathom Catalyst CenExel Intercept + Advanz About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly…
 
Pharma Q1 reports are rolling in, COVID boost turned sustainable, and weight loss battle looms Find out more at https://LifeScienceTodayPodcast.com Story References Merck Sanofi J&J ThermoFisher Novo Nordisk Eli Lilly About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly h…
 
Drops for reading, a $220M raise, and an acquisition straight out of the movies Find out more at https://LifeScienceTodayPodcast.com Story References Orasis Reify Blackrock + MindX About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pha…
 
The FDA asks for more diversity, $1B for injectors, $2B for a one-trick pony, and $68M to make DNA. Find out more at https://LifeScienceTodayPodcast.com Story References FDA Antares + Halozyme GSK + Sierra Ansa Biotechnologies About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect…
 
Viral therapies, rare disease approvals, and lab space premiums Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer + ReViral Novartis Charles River + Explora Labs About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technolog…
 
Big compensation, mild mergers, a Kite in an updraft, and tightening the biotech belt Find out more at https://LifeScienceTodayPodcast.com Story References Ginkgo Eagle + Acacia Gilead Taysha/Orchard/Silverback About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highligh…
 
$2 billion in capital raises mostly by companies that start with the letter A. Find out more at https://LifeScienceTodayPodcast.com Story References 2seventy Bio Ascendis Apellis Argenx About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies…
 
Case closed on patents, Alzheimer’s data, generic approvals, and expanded approvals. Find out more at https://LifeScienceTodayPodcast.com Story References Alexion + Chugai Biogen Viatris AbbVie About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new tech…
 
Technology for inclusion, layoffs, oncology approvals, and $200M for a tech platform. Find out more at https://LifeScienceTodayPodcast.com Story References Gilead AstraZeneca + Merck + Myriad DNAnexus About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about n…
 
Who owns CRISPR, a collaboration, the classics, and more money for biotech. Find out more at https://LifeScienceTodayPodcast.com Story References Sanofi + Adagene AbbVie + Syndesi Atlas About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies…
 
CRISPR works, the opioid epidemic makes amends (sort of), and the SPAC that wasn’t Find out more at https://LifeScienceTodayPodcast.com Story References Intellia Purdue Pharma Amicus SPAC About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologi…
 
The PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead Find out more at https://LifeScienceTodayPodcast.com Story References Eli Lilly + Innovent Biologics Agios TC Biopharm Blue Water Vaccines Meihua About the Show Life Science Today is your source for stories, insights, and trends across the life science industry…
 
Dragons over unicorns, to CRISPR and beyond, spin-out-and-sell, and expanded approvals. Find out more at https://LifeScienceTodayPodcast.com Story References Arcellx Intellia + Rewrite Navitor + Janssen ViiV About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights …
 
Bispecific antibodies, ocular oncology, Biogen sells, Lilly Builds, and the treatment of a lifetime Find out more at https://LifeScienceTodayPodcast.com Story References Genentech Immunocore Biogen Eli Lilly TenSixteen About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly …
 
Psychedelic SPACs, eczema frenzy, bio-outs without the biobucks, back on track, and the mega-deal that wasn’t Find out more at https://LifeScienceTodayPodcast.com Story References Eleusis Abbvie/Pfizer/Leo UCB + Zogenix Kura GSK - Unilever About the Show Life Science Today is your source for stories, insights, and trends across the life science ind…
 
Oncology partners, Parkinson’s partners, expanded European Commission, expanded FDA, and bacterial vaccines Find out more at https://LifeScienceTodayPodcast.com Story References Scorpion & AstraZeneca ABL & Sanofi Vertex Cochlear Vaxcyte About the Show Life Science Today is your source for stories, insights, and trends across the life science indus…
 
Devices with tech enablement, nano particles, Chinese approvals, and a massive series B for biotechnology Find out more at https://LifeScienceTodayPodcast.com Story References Stryker + Vocera Merck KGaA + Exelead BeiGene Eikon About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expec…
 
We’ve got a new name, gene therapy buyout, a lion of an approval, and an inescapable spotlight. Find out more at https://LifeScienceTodayPodcast.com Story References Novartis + Gyroscope Leo Biogen Biogen 2 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights a…
 
Acquiring the acquired, EHR acquisition, first approvals, and a new fund for the new year Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References CSL + Vifor Oracle + Cerner Calliditas Omega About the Show Life Science Today is your source for stories, insights, and trends across the life sci…
 
Antitrust AI, development AI, expanded approval, mega seeds, and biosimilar SPACs Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Microsoft + Nuance Roche + Recursion Heron 1E Alvotech About the Show Life Science Today is your source for stories, insights, and trends across the life s…
 
Double acquisitions in Switzerland, FDA holds and what that means, CMV therapy, rare + oncology continues, BioCryst draws millions, and deer. Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Vifor + Sanifit + Inositec Kura Differential Syndrome Takeda Aadi BioCryst USDA About the Show …
 
Top dollar lab notes, lab consolidation, RNA sells, and two new approval areas Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Benchling Labcorp Novo Nordisk BioMarin BioMarin 2 AppliedVR AppliedVR 2 Music by Luke Goodson https://www.soundcloud.com/lukegoodson About the Show Life Scie…
 
A giant breaks in two, acquisitions in women’s health, Medicare cost, rare approvals, more CRISPR, and a legacy Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Johnson & Johnson Organon Medicare PharmaEssentia Arbor Biotechnologies Glen de Vries About the Show Life Science Today is yo…
 
Roche and Novartis part ways, Alphabet likes AI, Pfizer 89%, Series A, B, and the money that gets you there Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Roche - Novartis Alphabet Pfizer Parthenon Antios Mission Bio Section 32 About the Show Life Science Today is your source for sto…
 
This week, we have a special bonus interview with Danielle Coe, founder of Black Women in Clinical Research. Danielle Coe Black Women in Clinical Research Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Background Danielle Coe started her career as a lab-based scientist, after learning from a friend a…
 
Unique therapies including anti-opioid overdose, ocular implants, fish skin, UV light, digital therapeutics, and the impact of approvals Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-074-1 https://tinyurl.com/Niche-074-2 https://tinyurl.com/Niche-074-3 http…
 
The 26-year pipeline, CMDO divestment, oncology, and movement among COVID19 Therapies Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-073-1 https://tinyurl.com/Niche-073-2 https://tinyurl.com/Niche-073-3 https://tinyurl.com/Niche-073-4 https://tinyurl.com/Nic…
 
Less than spiffy SPACs, big brains big money, Malaria buzz, vaccines, tests, series A, and Voyager gets a renewed lease on life Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-072-1 https://tinyurl.com/Niche-072-2 https://tinyurl.com/Niche-072-3 https://tinyu…
 
$11.5B acquisitions, we play “Who’s on First”, COVID19 therapy news, cancer Vaccines may be on the way, and CAR T for cancer is here to stay Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-071-1 https://tinyurl.com/Niche-071-2 https://tinyurl.com/Niche-071-3 …
 
Double approval, double acquisition, $200M for tests, $200M for prostate robots, $450M for $1B worth of gummies Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References https://tinyurl.com/Niche-070-1 https://tinyurl.com/Niche-070-2 https://tinyurl.com/Niche-070-3 https://tinyurl.com/Niche-070…
 
Originally Published as The Niche Podcast BeiGene’s oncology machine, China oncology pipelines, COVID costs, two new FDA approvals, $5B life science merger, and Hong Kong joins US SPAC party Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-069-1 https://tinyurl.com/Niche-069-2 https://tinyurl.com/Niche-069-3 https…
 
Originally Published as The Niche Podcast $1.5B deal, $1.9B merger, protein degraders get backing, an old bird has new tricks, and another billion-dollar valuation for CRISPR Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-068-1 https://tinyurl.com/Niche-068-2 https://tinyurl.com/Niche-068-3 https://tinyurl.com/N…
 
Originally Published as The Niche Podcast This week, I go on vacation and give you a special bonus interview with Sam Searcy, founder and CEO of CliniStart and former NC State Senator Find out more at https://thenichepod.com Story References https://clinistart.com/ https://www.samsearcy.com/ https://www.linkedin.com/in/samuel-searcy-3462891a4/ Musi…
 
Originally Published as The Niche Podcast The Cassava saga, Reify goes big… too big? Humacyte SPAC, vax news you already know, and a new growth hormone therapy – approved! Find out more at https://thenichepod.com Story References https://tinyurl.com/Niche-066-1 https://tinyurl.com/Niche-066-2 https://tinyurl.com/Niche-066-3 https://tinyurl.com/Nich…
 
Loading …

Quick Reference Guide

Copyright 2022 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login